Malkawi Ahmad Saleh, Haddad Razan, Malkawi Azhar, Alrabadi Nasr
Faculty of Pharmacy, Cyprus International University, Nicosia 99258 Cyprus.
Department of Pharmaceutical Sciences, Faculty of Pharmacy, Isra University, Queen Alya Airport Street, Amman 11622 Jordan.
Pharm Nanotechnol. 2022;10(2):146-161. doi: 10.2174/2211738510666220314103400.
In this study, four fluorescein hydrophobic ionic complexes were formed with the cationic polymers Eudragit RS, Eudragit RL, Eudragit E, and polyethyleneimine (PEI) to provide fluorescein sustained release, sustained cellular uptake, and stability.
Complexes were loaded in a self-emulsifying drug delivery system (SEDDS) composed of 40% Tween 80, 20% Kolliphor EL, 15% 2-n-Octyl-1-dodecanol, and 25% dipropylene glycol. SEDDS were investigated regarding their size, polydispersity index (PDI), zeta potential, and cytotoxicity. Fluorescein release from SEDDS was performed in phosphate buffer (pH 6.8 and pH 8), and the released fluorescein was evaluated for cellular uptake. Moreover, fluorescein from all of the SEDDS pre-concentrates was released at different time points to check its long-term stability over six months.
The average fluorescein load in SEDDS was 0.045%. SEDDS showed an average droplet size of 24.9 ± 1.6 nm with PDI ≤ 0.3. SEDDS complexes diluted 1:100 increased the zeta potential from -7.3 mV to +3.7 mV and provided > 85% cell viability. A 92.27 ± 3.18% fluorescein exhibited a few seconds of immediate release when used as control or PEI complex in SEDDS. On the contrary, Eudragit-fluorescein complexes in SEDDS showed sustained release of 87.01 ± 5.22% fluorescein in ≤ 70 min with 22.19 ± 14.56% and 59.27 ± 16.57% released at 10 min in pH 6.8 and pH 8 release media, respectively. Comparatively, the medium at pH 6.8 maintained a significantly improved sustained fluorescein release (p ≤ 0.001). Furthermore, Eudragit RS/RL compared to Eudragit E, significantly exhibited a slower fluorescein release rate from SEDDS (p ≤ 0.01). The cellular uptake of the released fluorescein was 72.4 ± 8.2% for all SEDDS complexes after 3 h. Eudragit complexes compared to PEI complex in SEDDS significantly showed m ore sustained fluorescein cellular uptake at 1 h and 2 h (p ≤ 0.001). However, SEDDS complexes showed the longest fluorescein stability with PEI after six months, whereas fluorescein stability for SEDDS containing fluorescein as Eudragit complex and control showed 39.1% and 82.5% fluorescence decrease, respectively, after three months.
In the developed SEDDS, the presence of hydrophobic ionic complexes can significantly promote longer stability and sustained cellular uptake of fluorescein while releasing in a sustained manner.
在本研究中,四种荧光素疏水离子复合物与阳离子聚合物Eudragit RS、Eudragit RL、Eudragit E和聚乙烯亚胺(PEI)形成,以实现荧光素的持续释放、细胞持续摄取及稳定性。
复合物被载入由40%吐温80、20%聚氧乙烯蓖麻油EL、15% 2 - 正辛基 - 1 - 十二烷醇和25%二丙二醇组成的自乳化药物递送系统(SEDDS)中。对SEDDS的粒径、多分散指数(PDI)、zeta电位和细胞毒性进行了研究。在磷酸盐缓冲液(pH 6.8和pH 8)中进行SEDDS中荧光素的释放,并对释放的荧光素进行细胞摄取评估。此外,在不同时间点释放所有SEDDS预浓缩物中的荧光素,以检查其在六个月内的长期稳定性。
SEDDS中荧光素的平均负载量为0.045%。SEDDS的平均液滴尺寸为24.9±1.6 nm,PDI≤0.3。稀释1:100的SEDDS复合物使zeta电位从 - 7.3 mV增加到 + 3.7 mV,并提供了>85%的细胞活力。当在SEDDS中用作对照或PEI复合物时,92.27±3.18%的荧光素表现出几秒的即刻释放。相反,SEDDS中的Eudragit - 荧光素复合物在≤70分钟内显示87.01±5.22%的荧光素持续释放,在pH 6.8和pH 8释放介质中10分钟时分别释放22.19±14.56%和59.27±16.57%。相比之下,pH 6.8的介质显著保持了更好的荧光素持续释放(p≤0.001)。此外,与Eudragit E相比,Eudragit RS/RL从SEDDS中释放荧光素的速率明显较慢(p≤0.01)。3小时后,所有SEDDS复合物释放的荧光素的细胞摄取率为72.4±8.2%。与SEDDS中的PEI复合物相比,Eudragit复合物在1小时和2小时时显著显示出更持续的荧光素细胞摄取(p≤0.001)。然而,六个月后,含PEI的SEDDS复合物显示荧光素稳定性最长,而含Eudragit复合物和对照的SEDDS中荧光素稳定性在三个月后分别显示荧光下降39.1%和82.5%。
在开发的SEDDS中,疏水离子复合物能够显著促进荧光素更长时间的稳定性和细胞持续摄取,同时实现持续释放。